As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
|Articles|March 20, 2023
PAP 2023: Vijesh Unnikrihnan Discusses Questions from Taking a Digital-First Approach to Solving the Fragmented Support Service Experience at Access PAP 2023
ZS lead speaks on questions asked during his Taking a Digital-First Approach session.
Advertisement
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Vijesh Unnikrihnan, digital health strategy lead, ZS, addresses questions that were asked during "Taking a Digital-First Approach" session.
Advertisement
Related to this article
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's five-year evolution and where serialized data is creating value beyond compliance.
HDA's Kala Shankle unpacks the biggest open question on preemption and offers a two-step playbook for wholesalers and 3PLs preparing for national licensure.
Cardinal Health's Liberty Dewey outlines the four parallel work streams driving the NDC-12 transition, and why the biggest risk sits in trading partner handoffs rather than any single system.
Sponsored
Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.
Sponsored
Logan Melchione shares how ClaimGuardRx gives account teams a fast, conversational way to tackle diversion and fraud together, and what that means for clients and patients.
Sponsored
Bryan Dennison breaks down the purpose-built technology behind ClaimGuardRx and how its detect-and-respond design keeps manufacturers ahead of evolving diversion tactics.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
EU Pharma Reform: Strategic Implications for US Drugmakers
2
How Rebate Timing Distorts a Pharmacy's 340B Books
3
White House Extends MFN Pricing to Every State Medicaid Program
4
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
5